Guttate Psoriasis clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 18 years and up
This is a two-arm open-label study to evaluate the clinical and immunogenetic responses of patients with plaque or guttate psoriasis to treatment with guselkumab.
San Francisco, California
Our lead scientists for Guttate Psoriasis medical studies include Wilson Liao, MD.